ID

43572

Description

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole; ODM derived from: https://clinicaltrials.gov/show/NCT00316836

Link

https://clinicaltrials.gov/show/NCT00316836

Keywords

Versions (2)
  1. 1/11/17 1/11/17 -
  2. 9/20/21 9/20/21 -
Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00316836

English

Eligibility Breast Cancer NCT00316836

1 forms  
Criteria
Description

Criteria

histologically confirmed invasive breast cancer
Description

Invasive carcinoma of breast

Data type

boolean

Alias
UMLS CUI [1]
C0853879
completely resected disease
Description

Disease Complete excision

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0015250
one intact, noncancerous breast with no prior breast surgery in that breast except breast biopsy
Description

Breast One Intact | Operation on breast | Biopsy of breast

Data type

boolean

Alias
UMLS CUI [1,1]
C0006141
UMLS CUI [1,2]
C0205447
UMLS CUI [1,3]
C0205266
UMLS CUI [2]
C3714726
UMLS CUI [3]
C0405352
mammogram available taken within 12 months prior to enrollment that includes side- and top-down views of the intact, noncancerous breast
Description

Mammogram Available Breast Intact

Data type

boolean

Alias
UMLS CUI [1,1]
C0024671
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C0006141
UMLS CUI [1,4]
C0205266
estrogen receptor- and/or progesterone receptor-positive tumor
Description

Estrogen receptor positive tumor | Progesterone receptor positive tumor

Data type

boolean

Alias
UMLS CUI [1]
C1562312
UMLS CUI [2]
C1562928
patient characteristics:
Description

Client Characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0815172
female
Description

Gender

Data type

boolean

Alias
UMLS CUI [1]
C0079399
postmenopausal
Description

Postmenopausal state

Data type

boolean

Alias
UMLS CUI [1]
C0232970
agrees to retrieve and digitize mammograms taken prior to registration (within 12 months prior to atudy entry) and at approximately 1 and 2 years post-registration to this study
Description

Mammogram Repeat Agreement

Data type

boolean

Alias
UMLS CUI [1,1]
C0024671
UMLS CUI [1,2]
C0205341
UMLS CUI [1,3]
C0680240
agrees to have an additional blood banking specimen drawn at the same time as pre-treatment specimens are drawn for parent protocol can-ncic-ma27
Description

Blood Bank Specimen Additional Agreement

Data type

boolean

Alias
UMLS CUI [1,1]
C0005770
UMLS CUI [1,2]
C0370003
UMLS CUI [1,3]
C1524062
UMLS CUI [1,4]
C0680240
agrees to have blood sample taken at 12 months post-registration on this study
Description

Blood sample Agreement

Data type

boolean

Alias
UMLS CUI [1,1]
C0178913
UMLS CUI [1,2]
C0680240
prior concurrent therapy:
Description

Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Description

disease characteristic

Data type

boolean

Alias
UMLS CUI [1]
C0599878
more than 6 months since prior hormone replacement therapy, oral contraceptives, tamoxifen, raloxifene, other selective estrogen-receptor modulators, or gonadotropin releasing-hormone analogues before pre-registration mammogram
Description

Hormone replacement therapy | Contraceptives, Oral | Tamoxifen | Raloxifene | Selective Estrogen Receptor Modulators | Gonadotropin-Releasing Hormone Analog

Data type

boolean

Alias
UMLS CUI [1]
C0282402
UMLS CUI [2]
C0009905
UMLS CUI [3]
C0039286
UMLS CUI [4]
C0244404
UMLS CUI [5]
C0732611
UMLS CUI [6]
C1518041
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT00316836

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Invasive carcinoma of breast
Item
histologically confirmed invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Disease Complete excision
Item
completely resected disease
boolean
C0012634 (UMLS CUI [1,1])
C0015250 (UMLS CUI [1,2])
Breast One Intact | Operation on breast | Biopsy of breast
Item
one intact, noncancerous breast with no prior breast surgery in that breast except breast biopsy
boolean
C0006141 (UMLS CUI [1,1])
C0205447 (UMLS CUI [1,2])
C0205266 (UMLS CUI [1,3])
C3714726 (UMLS CUI [2])
C0405352 (UMLS CUI [3])
Mammogram Available Breast Intact
Item
mammogram available taken within 12 months prior to enrollment that includes side- and top-down views of the intact, noncancerous breast
boolean
C0024671 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C0205266 (UMLS CUI [1,4])
Estrogen receptor positive tumor | Progesterone receptor positive tumor
Item
estrogen receptor- and/or progesterone receptor-positive tumor
boolean
C1562312 (UMLS CUI [1])
C1562928 (UMLS CUI [2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Gender
Item
female
boolean
C0079399 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
Mammogram Repeat Agreement
Item
agrees to retrieve and digitize mammograms taken prior to registration (within 12 months prior to atudy entry) and at approximately 1 and 2 years post-registration to this study
boolean
C0024671 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
C0680240 (UMLS CUI [1,3])
Blood Bank Specimen Additional Agreement
Item
agrees to have an additional blood banking specimen drawn at the same time as pre-treatment specimens are drawn for parent protocol can-ncic-ma27
boolean
C0005770 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
C0680240 (UMLS CUI [1,4])
Blood sample Agreement
Item
agrees to have blood sample taken at 12 months post-registration on this study
boolean
C0178913 (UMLS CUI [1,1])
C0680240 (UMLS CUI [1,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
disease characteristic
Item
see disease characteristics
boolean
C0599878 (UMLS CUI [1])
Hormone replacement therapy | Contraceptives, Oral | Tamoxifen | Raloxifene | Selective Estrogen Receptor Modulators | Gonadotropin-Releasing Hormone Analog
Item
more than 6 months since prior hormone replacement therapy, oral contraceptives, tamoxifen, raloxifene, other selective estrogen-receptor modulators, or gonadotropin releasing-hormone analogues before pre-registration mammogram
boolean
C0282402 (UMLS CUI [1])
C0009905 (UMLS CUI [2])
C0039286 (UMLS CUI [3])
C0244404 (UMLS CUI [4])
C0732611 (UMLS CUI [5])
C1518041 (UMLS CUI [6])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial